FIELD: medicine.
SUBSTANCE: invention relates to the field of genetic engineering and medicine. Claimed method of treating neurodegenerative diseases and Alzheimer's disease, including intranasal introduction to the subject of a therapeutically effective quantity of YB-1 protein, possessing an amino acid sequence of human SEQ ID NO:1 or rabbit SEQ ID NO:7 and/or its active fragment separately or in a composition, which additionally contains one or several agents, which enhance the intranasal delivery of the composition to the brain.
EFFECT: invention ensures the efficiency of low doses of the protein, reduction of side effects, as well as a possibility of applying the highly-purified genetically-engineered protein.
6 cl, 8 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TARGETED NON-INVASIVE TRANSPLANTATION INTO BRAIN OF FUNCTIONALLY ACTIVE MITOCHONDRIA FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2744453C2 |
| PEPTIDE HAVING LYNX1 PROTEIN ACTIVITY (EMBODIMENTS), PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDERS AND DEPRESSION OR CORRECTION OF COGNITIVE DISORDERS IN NEURODEGENERATIVE DISEASES, CONTAINING SAID PEPTIDE, AND METHOD OF TREATING AND CORRECTING SAID DISORDERS | 2020 |
|
RU2734649C1 |
| PEPTIDE HAVING NEUROPROTECTIVE AND NOOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2014 |
|
RU2557003C2 |
| 4-(3-((2-ADAMANTYL)AMINO)-3-OXOPROP-1-EN-1-YL)-N-HYDROXYBENZAMIDE - A NEW DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE | 2022 |
|
RU2783995C1 |
| PEPTIDE HAVING CURATIVE EFFECT AGAINST ALZHEIMER DISEASE | 2014 |
|
RU2558242C1 |
| INTERLEUKIN-10, USING IT AND BASED COMPOSITION FOR TREATING BRAIN NEURODEGENERATIVE PROCESSES | 2012 |
|
RU2538613C2 |
| METHOD FOR DEVELOPING ALZHEIMER DISEASE CELL MODELS | 2013 |
|
RU2544957C2 |
| PEPTIDE WITH TREATMENT ACTION AGAINST ALZHEIMER'S DISEASE | 2016 |
|
RU2626972C2 |
| EXOGENIC-INDUCED ANIMAL MODEL OF ALZHEIMER DISEASE | 2012 |
|
RU2532525C2 |
| METHOD OF DETECTING AMYLOID PEPTIDE MODIFICATIONS USING HIGH-SPECIFIC ANTIBODIES | 2019 |
|
RU2708465C1 |
